Organizations are integrating previously disparate services to better align their offerings with the shift from fee-for-service to risk-based care through visionary, member-centric solutions. For ...
Clinical trials can often take between six and seven years to complete, but that timeline isn’t always practical for the problems pharmaceutical companies are trying to solve. Additionally, six years ...
WASHINGTON--(BUSINESS WIRE)--Risk-based monitoring (RBM) is a powerful tool for efficiently ensuring patient safety and data integrity in a clinical trial, enhancing overall trial quality. To better ...
New offering improves the quality and predictability of clinical development while reducing overall trial costs by up to 25 percent RESEARCH TRIANGLE PARK, NC – Quintiles today announced the launch of ...
The American Gastroenterology Association (AGA) Institute issued new clinical practice guidelines, providing evidence-based recommendations for managing hepatitis B reactivation (HBVr) in at-risk ...
Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Clinical Trial Risk Management - ICH E6(R3) and FDA Expectations (Sept 5, 2025)" training has been added to ResearchAndMarkets.com's offering .This ...
Regulators require that financial services companies take a risk-based approach (RBA) to maintain compliance, which can seem like a heavy burden on businesses in terms of costs, workforce and ...
If most midsize companies have a formal risk management process, why did so many fail even in pre-pandemic years? The problem is that risk heat maps — many companies’ primary tool for assessing risk — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback